BHP Group Limited

BHP

BHP Group Ltd. engages in the exploration, development, production and processing of iron ore, metallurgical coal, and copper. The company is headquartered in Melbourne, Victoria and currently employs 39,729 full-time employees. The firm is a producer of commodities, including iron ore, copper, nickel, potash and metallurgical (steelmaking) coal. The company is focused on offering a range of resources, which provides copper for renewable energy; nickel for electric vehicles; potash for sustainable farming, and iron ore and metallurgical coal for the steel needed for global infrastructure and the energy transition. Its segments include Copper, Iron Ore, and Coal. Its Copper segment is engaged in mining of copper, silver, zinc, molybdenum, uranium, and gold. Its Iron Ore segment is engaged in mining of iron ore. Its Coal segment is engaged in mining of metallurgical coal and energy coal. The firm is also focused on operating Olympic Dam, Prominent Hill, and Carrapateena underground copper-gold mines in South Australia. Its operations are situated in Australia, Europe, China, Japan, India, South Korea, rest of Asia, North America, South America, and others.

Botanix Pharmaceuticals Ltd

BOT

Botanix Pharmaceuticals Ltd. is a dermatology company, which engages in the business of researching and developing dermatology and antimicrobial products. The company is headquartered in Perth, Western Australia. The firm is engaged in the development and commercialization of treatments for common skin diseases and infections. Its lead product is Sofpironium Bromide, for the treatment of primary axillary hyperhidrosis. The company also has a pipeline of other products in late-stage clinical studies for the treatment of moderate to severe rosacea, dermatitis, and acne respectively. The company also developing a topical antimicrobial product for the eradication of bacteria on the skin surface, initially in patients who are undergoing hemodialysis. Its BTX1503 product is a transdermal gel formulation for the treatment of serious acne in adults and teenagers. Its BTX1702 product for the treatment of papulopustular rosacea. Its BTX 1204A canine study in Australia and New Zealand for atopic dermatitis. Its BTX1801 is an antimicrobial gel focused on targeting Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus.

Bounty Oil & Gas NL

BUY

Bounty Oil & Gas NL engages in the exploration, development, production, and marketing of oil and gas. The company is headquartered in Sydney, New South Wales. The company went IPO on 2002-02-05. The firm is engaged in exploration, development, production and marketing of oil and gas (petroleum). The company is also involved in the investment in listed entities. The company has production and exploration operations in three states within Australia. Its operations include PEP 11, Cerberus, Carnarvon Basin, Naccowlah Block and Surat Basin. PEP 11 covers 4,576 square kilometers (km2) of the offshore Sydney Basin adjacent to the gas market in Australia. The Cerberus Project incorporates 3,578 km2 in four permits, EP 475, 490, 491 and TP 27 offshore Carnarvon Basin and lies 70 kilometers (km) east of Barrow Island. The company monitors the Rough Range 1B well in petroleum license L 16 onshore Carnarvon Basin, which is surrounding Rough Range Oil Field, 60 km South of Exmouth. The firm owns a 2% interest in the Naccowlah Block, which is located in southwest (SW) Queensland and covers an area of 1,064 km2.

BPH Energy Ltd

BPH

BPH Energy Ltd. engages in investments in biotechnology and oil and gas exploration entities. The company is headquartered in Perth, Western Australia. The company went IPO on 2004-08-06. The firm holds a significant interest in an unlisted oil and gas exploration company. The Company’s principal activities include investments in various companies, which include Clean Hydrogen Technologies Corporation (Clean Hydrogen Technologies), Cortical Dynamics Limited (Cortical), Advent Energy Limited, and Molecular Discovery Systems Limited (MDSystems). Clean Hydrogen Technologies is a USA Delaware registered company with technology to produce clean hydrogen. The Advent Energy Limited is an unlisted oil and gas exploration and production company based in Perth, Western Australia. The Cortical is a medical device company focused on developing brain function monitors by employing theories and technologies in the field. MDSystems focuses on drug discovery and the validation of biomarkers for disease, therapy and diagnostics.

Bannerman Energy Ltd

BMN

Bannerman Energy Ltd. engages in the exploration and operation of uranium mining projects. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2005-04-28. The firm's flagship asset is the 95% owned Etango Uranium Project that is located in the Erongo Region of Namibia, approximately 30 kilometers south-east of Swakopmund. The Etango Uranium Project possesses a uranium mineral resource endowment of 207 million pounds (Mlbs) of contained U3O8. The Etango Uranium Project is an undeveloped uranium deposits, located in the Erongo uranium mining region of Namibia which hosts the Rossing, Husab and Langer-Heinrich mines. The firm's subsidiaries include Bannerman Mining Resources (Namibia) (Pty) Ltd, Bannerman Energy (UK) Limited, Bannerman Investments Pty Ltd, Bannerman Energy Canada Ltd and Bannerman Energy (Netherlands) B.V.